Trial Profile
Optimization of Golimumab Treatment in Ulcerative Colitis
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 16 May 2022
Price :
$35
*
At a glance
- Drugs Golimumab (Primary)
- Indications Ulcerative colitis
- Focus Pharmacodynamics; Pharmacokinetics; Therapeutic Use
- 20 Sep 2018 New trial record